Sacubitril/Valsartan for Blood Pressure Lowering in Non-Dialysis-Dependent Chronic Kidney Disease Stage 3-5 Patients With Hypertension: A Multicenter Clinical Study.

When aiming for a target of less than 130/80 mmHg, the blood pressure control rates of patients in Stages 3 and 4 significantly increased post‐treatment ( p < 0.001, p < 0.01), while for Stage 5 patients, although the difference in blood pressure control rates before and after medication was not significant from a statistical perspective ( p = 0.11), there was an increasing trend in blood pressure control rates after medication (Figure S1 ).

also in 63,971 other papers